Antonio Bellasi1, Emiliana Ferramosca2, Carlo Ratti3, Geoffrey Block4, Paolo Raggi5. 1. Nephrology Unit, ASST-Lariana, Ospedale Sant'Anna, Como, Italy; Department of Health Sciences, University of Milan, Milan, Italy. 2. Nephrology Unit, Unità Operativa Presidio Ospedale "Vito Fazzi", Lecce, Italy. 3. Division of Cardiology, Ospedale Civile Ramazzini, Carpi, MO, Italy. 4. Denver Nephrology, Denver, CO, USA. 5. Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada. Electronic address: raggi@ualberta.ca.
Abstract
BACKGROUND AND AIM: In the general population lipid-rich plaques are prone to rupture and healing of the plaque involves calcification. Patients undergoing hemodialysis have a severe derangement of mineral metabolism and calcification of the arterial tree may have different implications. METHODS: Between 2004 and 2005, 125 hemodialysis patients (60 men) underwent computed tomography imaging for quantification of coronary artery calcium via the Agatston and the Volume methods. Since the Agatston score is derived by multiplying the density by the volume of a calcified lesion, the Agatston/Volume ratio (AVR) is an indication of the density (i.e. calcium accumulation) within the plaque. RESULTS: Patients were classified as high AVR (>1) or low (≤1) AVR. Survival analyses tested the association between AVR and all-cause mortality during a median follow-up of 5 years. The mean age was 57.2±13.5 years; 75% of the patients had AVR >1. The mortality rate of patients with AVR >1 was significantly higher than in patients with AVR ≤1 (Hazard Ratio(HR): 2.46; 95% Confidence Intervals(CI): 1.16-5.21, p ≤0.018). After adjustment for confounders, AVR >1 remained independently associated with all-cause mortality (HR: 2.24; 95% CI: 1.02-4.88, p ≤0.042). There was a significant interaction of plaque density and calcium volume on mortality. CONCLUSIONS: Increased plaque density is an independent predictor of all-cause mortality in hemodialysis patients. These data suggest that increased calcium content in the coronary arteries of patients in dialysis is an index of high-risk rather than a marker of plaque stabilization.
BACKGROUND AND AIM: In the general population lipid-rich plaques are prone to rupture and healing of the plaque involves calcification. Patients undergoing hemodialysis have a severe derangement of mineral metabolism and calcification of the arterial tree may have different implications. METHODS: Between 2004 and 2005, 125 hemodialysis patients (60 men) underwent computed tomography imaging for quantification of coronary artery calcium via the Agatston and the Volume methods. Since the Agatston score is derived by multiplying the density by the volume of a calcified lesion, the Agatston/Volume ratio (AVR) is an indication of the density (i.e. calcium accumulation) within the plaque. RESULTS:Patients were classified as high AVR (>1) or low (≤1) AVR. Survival analyses tested the association between AVR and all-cause mortality during a median follow-up of 5 years. The mean age was 57.2±13.5 years; 75% of the patients had AVR >1. The mortality rate of patients with AVR >1 was significantly higher than in patients with AVR ≤1 (Hazard Ratio(HR): 2.46; 95% Confidence Intervals(CI): 1.16-5.21, p ≤0.018). After adjustment for confounders, AVR >1 remained independently associated with all-cause mortality (HR: 2.24; 95% CI: 1.02-4.88, p ≤0.042). There was a significant interaction of plaque density and calcium volume on mortality. CONCLUSIONS: Increased plaque density is an independent predictor of all-cause mortality in hemodialysis patients. These data suggest that increased calcium content in the coronary arteries of patients in dialysis is an index of high-risk rather than a marker of plaque stabilization.
Authors: An S De Vriese; Rogier Caluwé; Lotte Pyfferoen; Dirk De Bacquer; Koen De Boeck; Joost Delanote; Didier De Surgeloose; Piet Van Hoenacker; Bruno Van Vlem; Francis Verbeke Journal: J Am Soc Nephrol Date: 2019-11-08 Impact factor: 10.121
Authors: Borek Foldyna; Parastou Eslami; Jan-Erik Scholtz; Kristin Baltrusaitis; Michael T Lu; Joseph M Massaro; Ralph B D'Agostino; Maros Ferencik; Hugo J W L Aerts; Christopher J O'Donnell; Udo Hoffmann Journal: Eur Radiol Date: 2019-05-02 Impact factor: 5.315
Authors: Nketi I Forbang; Erin D Michos; Robyn L McClelland; Rosemay A Remigio-Baker; Matthew A Allison; Veit Sandfort; Joachim H Ix; Isac Thomas; Dena E Rifkin; Michael H Criqui Journal: Circ Cardiovasc Imaging Date: 2016-11 Impact factor: 7.792
Authors: Allison L Kuipers; Joseph M Zmuda; J Jeffrey Carr; James G Terry; Sangeeta Nair; Ryan Cvejkus; Clareann H Bunker; Alan L Patrick; Christina L Wassel; Iva Miljkovic Journal: Atherosclerosis Date: 2017-06-16 Impact factor: 5.162
Authors: Connie M Rhee; Matthew Budoff; Gregory Brent; Amy S You; Peter Stenvinkel; Alejandra Novoa; Ferdinand Flores; Sajad Hamal; Christopher Dailing; April Kinninger; Tracy Nakata; Csaba P Kovesdy; Danh V Nguyen; Kamyar Kalantar-Zadeh Journal: Cardiorenal Med Date: 2022-05-12 Impact factor: 4.360
Authors: Paul Anaya; Gustav A Blomquist; Daniel L Davenport; Marie-Claude Monier-Faugere; Vincent L Sorrell; Hartmut H Malluche Journal: Clin Nephrol Date: 2016-12 Impact factor: 0.975
Authors: Thijs T Jansz; Meike H Y Go; Nolan S Hartkamp; J Lauran Stöger; Csilla Celeng; Tim Leiner; Pim A de Jong; Frank J L Visseren; Marianne C Verhaar; Brigit C van Jaarsveld Journal: Kidney Med Date: 2021-04-20
Authors: Antonio Bellasi; Luca Di Lullo; Domenico Russo; Roberto Ciarcia; Michele Magnocavallo; Carlo Lavalle; Carlo Ratti; Mario Cozzolino; Biagio Raffaele Di Iorio Journal: Cells Date: 2021-05-03 Impact factor: 6.600